Business
Patients Dosed in R327 Diabetic Foot Infection Trial
Patients Dosed in R327 Diabetic Foot Infection Trial
About this update from Recce Pharmaceuticals Ltd.
[{"type":"text","content":"Recce Ltd has released a press release. View Attachment","length":231,"tagName":"div"}]